antimetabolites
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for antimetabolites, covering 2022-08-03 to 2022-08-03. Get the full timeline:
Most recent: Clinical Trial Update: A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy [Phase 4]